Market Place
Sourcing Support
All News #Library
Biotech
Osivax Completes Enrollment in Phase 2b Asuniva Trial for OVX836
09 Dec 2025 //
GLOBENEWSWIRE
Osivax Starts Ph 2b Trial Of Broad-Spectrum Influenza A Vaccine
16 Sep 2025 //
GLOBENEWSWIRE
Osivax Secures $19.5M BARDA Award for Advanced Influenza Vaccine
26 Aug 2025 //
GLOBENEWSWIRE
Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2a
12 Jul 2025 //
GLOBENEWSWIRE
Osivax Backs OVX836 Co-Administration with Flu Shot in Phase 2A
10 Jul 2025 //
GLOBENEWSWIRE
Osivax Announces Phase 2a Trial Completion for Influenza Vaccine
05 Jun 2025 //
GLOBENEWSWIRE
Osivax Secures Funding To Advance Influenza Vaccine Development
04 Mar 2025 //
BUSINESSWIRE
Osivax Vaccinates First Participant in OVX836 Booster Trial
14 Nov 2024 //
BUSINESSWIRE
Osivax-KM Biologics License For Universal Flu Vaccine In Japan
10 Sep 2024 //
BUSINESSWIRE
Osivax completes enrollment for Phase 1 trial of OVX033
25 Jun 2024 //
BUSINESSWIRE
Osivax Announces Vaccination of Last Patient in Ph 2a Trial Evaluating OVX836
26 Mar 2024 //
BUSINESSWIRE
Osivax Announces Vaccination of First Participant in Trial Evaluating OVX033
15 Feb 2024 //
BUSINESSWIRE
Osivax Receives USD 1.5M Grant from NIAID to Advance Development of OVX836
05 Dec 2023 //
BUSINESSWIRE
Osivax Announces Publicationof Ph 2a Data for OVX836
27 Jul 2023 //
BUSINESSWIRE
Osivax Publishes Data for Sarbecovirus Vaccine Candidate, OVX033
06 Jul 2023 //
BUSINESSWIRE
Osivax Announces Vaccination of Participant in Phase 2a Trial Evaluating OVX836
15 Jun 2023 //
BUSINESSWIRE
Osivax Awarded Grant from a Leading Non-Governmental Organization for OVX836
28 Mar 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.